Does MASITINIB Cause Second primary malignancy? 7 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 7 reports of Second primary malignancy have been filed in association with MASITINIB. This represents 46.7% of all adverse event reports for MASITINIB.
7
Reports of Second primary malignancy with MASITINIB
46.7%
of all MASITINIB reports
5
Deaths
0
Hospitalizations
How Dangerous Is Second primary malignancy From MASITINIB?
Of the 7 reports, 5 (71.4%) resulted in death.
Is Second primary malignancy Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for MASITINIB. However, 7 reports have been filed with the FAERS database.
What Other Side Effects Does MASITINIB Cause?
What Other Drugs Cause Second primary malignancy?
CYCLOPHOSPHAMIDE (1,247)
DOXORUBICIN (1,151)
VINCRISTINE (908)
IMATINIB (763)
PALBOCICLIB (658)
RITUXIMAB (646)
RUXOLITINIB (611)
ETOPOSIDE (573)
PREDNISONE (517)
OCTREOTIDE (496)